Infections in IVF: review and guidelines

被引:54
作者
Steyaert, SR
Leroux-Roels, GG
Dhont, M
机构
[1] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Obstet & Gynecol, B-9000 Ghent, Belgium
关键词
biosafety; contamination; ethics; IVF; screening;
D O I
10.1093/humupd/6.5.432
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Since the inception of in-vitro fertilization (IVF), questions about contamination and the transmission of infection have been raised. In this review, screening for Chlamydia trachomatis, as well as medical and ethical considerations on IVF in couples infected with hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV), are discussed. IVF is not contraindicated in case of HBV or HCV infection, but the decision is far more delicate in case of HIV infection, If donor gametes or embryos are used, prevention of infectious disease transmission resides in accurate donor selection, including screening for C, trachomatis, HIV, HBV, cytomegalovirus and Treponema pallidum. In the embryology laboratory, microbial contamination of the IVF system deserves attention, and can be prevented by using sterile technique and supplementing culture media with screened sera or serum substitutes and antibiotics. Persons whose biological material is to be cryopreserved should be screened for HBV, HCV and HIV, and separate containers should be used for infected and non-infected material. Finally, transmission of infectious diseases to laboratory personnel can be prevented by adherence to strict safety guidelines, wearing of protective clothing, HBV vaccination, prohibition of mouth pipetting, and developing a plan for the disposal of bio-hazardous material.
引用
收藏
页码:432 / 441
页数:10
相关论文
共 111 条
[51]   IMPROVED METHODS FOR PREPARATION OF CULTURE MEDIA FOR INVITRO FERTILIZATION AND GAMETE INTRAFALLOPIAN TRANSFER [J].
HAMMITT, DG ;
WALKER, DL ;
SYROP, CH .
HUMAN REPRODUCTION, 1990, 5 (04) :457-463
[52]   The impact of HIV on a fertility problems clinic [J].
Hargreave, TB ;
Ghosh, C .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 41 (1-2) :261-270
[53]  
HEWITT J, 1985, Journal of In Vitro Fertilization and Embryo Transfer, V2, P105, DOI 10.1007/BF01139342
[54]   Syphilis [J].
Hollier, LM ;
Cox, SM .
SEMINARS IN PERINATOLOGY, 1998, 22 (04) :323-331
[55]   MICROBIAL-FLORA IN SEMEN DURING INVITRO FERTILIZATION [J].
HUYSER, C ;
FOURIE, FL ;
OOSTHUIZEN, M ;
NEETHLING, A .
JOURNAL OF IN VITRO FERTILIZATION AND EMBRYO TRANSFER, 1991, 8 (05) :260-264
[56]   COMPARISON OF THE ABILITY OF 2 SPERM PREPARATION TECHNIQUES TO REMOVE MICROBES [J].
KARLSTROM, PO ;
HJELM, E ;
LUNDKVIST, O .
HUMAN REPRODUCTION, 1991, 6 (03) :386-389
[57]   Prospective randomized study comparing human serum albumin with fetal cord serum as protein supplement in culture medium for in-vitro fertilization [J].
Laverge, H ;
De Sutter, P ;
Desmet, R ;
Van der Elst, J ;
Dhont, M .
HUMAN REPRODUCTION, 1997, 12 (10) :2263-2266
[58]  
LENS JW, 1996, LAB ASPECTS IN VITRO, P177
[59]   TRANSVAGINAL RECOVERY OF OOCYTES FOR INVITRO FERTILIZATION USING VAGINAL ULTRASOUND [J].
LENZ, S ;
LEETON, J ;
RENOU, P .
JOURNAL OF IN VITRO FERTILIZATION AND EMBRYO TRANSFER, 1987, 4 (01) :51-55
[60]   Transmissions of hepatitis C virus during the ancillary procedures for assisted conception [J].
Lesourd, F ;
Izopet, J ;
Mervan, C ;
Payen, JL ;
Sandres, K ;
Monrozies, X ;
Parinaud, J .
HUMAN REPRODUCTION, 2000, 15 (05) :1083-1085